Tumor Response Rate (trr) - Cancer Science

Relevant Publications

Adjuvant treatment with Cordyceps sinensis for lung cancer: A systematic review and meta-analysis of randomized controlled trials.

Issue Release: 2024

Efficacy and safety of 3-dimensional printing noncoplanar template (3D-PNCT)-assisted high-dose-rate interstitial brachytherapy (HDR-ISBT) for reirradiation of recurrent cervical cancer: a prospective cohort.

Issue Release: 2024

Predicting Pathological Complete Response in Breast Cancer After Two Cycles of Neoadjuvant Chemotherapy by Tumor Reduction Rate: A Retrospective Case-Control Study.

Issue Release: 2023

Serum Colorectal Neoplasia Differentially Expressed Level and Prognostic Factors in Patients with RLNM of NPC.

Issue Release: 2023

An open, observational, three-arm clinical study of 2-3 cycles of treatment as neoadjuvant therapy in operable locally advanced non-small cell lung cancer: An interim analysis.

Issue Release: 2022

Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatment.

Issue Release: 2022

A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO).

Issue Release: 2022

Meta-Analysis of Paclitaxel-Based Chemotherapy Combined With Traditional Chinese Medicines for Gastric Cancer Treatment.

Issue Release: 2020

Analysis of Response Evaluation Criteria in Solid Tumors reduction ratio of primary chemotherapy in unresectable advanced or recurrent colorectal cancer.

Issue Release: 2019

Meta-Analysis of Astragalus-Containing Traditional Chinese Medicine Combined With Chemotherapy for Colorectal Cancer: Efficacy and Safety to Tumor Response.

Issue Release: 2019

Add-On Therapy with Traditional Chinese Medicine Improves Outcomes and Reduces Adverse Events in Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials.

Issue Release: 2017

Meta-Analysis of Oxaliplatin-Based Chemotherapy Combined With Traditional Medicines for Colorectal Cancer: Contributions of Specific Plants to Tumor Response.

Issue Release: 2015

FOLFOX 4 combined with herbal medicine for advanced colorectal cancer: a systematic review.

Issue Release: 2013

Assessment of tumor response as a surrogate endpoint of survival in recurrent/platinum-resistant ovarian carcinoma: a Gynecologic Oncology Group study.

Issue Release: 2010

A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma: a phase 2 consortium study.

Issue Release: 2010

Preliminary results of a phase III trial of spontaneous animal tumors to heat and/or radiation: early normal tissue response and tumor volume influence on initial response.

Issue Release: 1982

Meta-Analysis of 5-Fluorouracil-Based Chemotherapy Combined With Traditional Chinese Medicines for Colorectal Cancer Treatment.

Issue Release: 0000

A fractal dimension analysis: a new method for evaluating the response of anticancer therapy.

Issue Release: 0000

What Are the Challenges in Single Cell Omics in Cancer?

What are Vials and Ampoules?

How Does PSA Density Compare to Other Diagnostic Tools?

What are the Therapeutic Implications of Targeting PAX3?

How Do Innovations in Cancer Treatment Affect Complications?

What are the benefits of using Plerixafor?

Can RNA Transcripts Inform Cancer Treatment?

What Does Balancing Risks and Benefits Mean in Cancer Treatment?

Can Lifestyle Changes Impact Cancer Risk for BRCA Mutation Carriers?

What Role Do Mutated Antigens Play in Immunotherapy?

Tumor Response Rate (trr) - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics